USD0.000æéå€ååŒÂ  (ET)
1.53BæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
ç«¶åä»ç€Ÿ
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
ç«¶åä»ç€Ÿ
TradingKeyã®Enovis Corpã®æ ªåŒã¹ã³ã¢
é貚: USD æŽæ°æå»: 2025-12-24 äž»èŠã€ã³ãµã€ã
Enovis Corpã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãã å»çæ©åš & å忥çã®ã©ã³ãã³ã°ã¯43/206äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯48.11ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããæ ªåŒåžå Žã§ã®ããã©ãŒãã³ã¹ã¯ãã®1ãæã§äœèª¿ã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Enovis Corpã®ã¹ã³ã¢î°î°
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
Enovis Corpã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
å¥å
šæ§
é貚: USD æŽæ°æå»: 2025-12-24 Enovis Corpã®çŸåšã®è²¡åã¹ã³ã¢ã¯6.97ã§ãå»çæ©åš & å忥çã«ãããã©ã³ãã³ã°ã¯114/206äœã§ãã ãã®è²¡åç¶æ³ã¯å®å®ã§ãã ãŸããäºæ¥å¹çã¯å¹³åçã§ãã ææ°ååæã®å£²äžé«ã¯548.91Mã§ãåå¹Žåææ¯å¢å ã®8.65%ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯å¢å ã®1711.95%ãšãªããŸããã
é¢é£èšäº
çŸéããã³çŸéåçç©
ç·è³ç£
è² åµåèš
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ç·å£²äžé«
å¶æ¥å©ç
ç·è³ç£
販売費 & äžè¬ç®¡çè²»

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
çšåŒåŸå©ç

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Enovis Corpã®äŒæ¥äŸ¡å€è©äŸ¡
é貚: USD æŽæ°æå»: 2025-12-24Enovis Corpã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯8.24ã§ãå»çæ©åš & å忥çã§ã¯35/206äœã§ãã çŸåšã®PERã¯-1.10ã§ãçŽè¿é«å€-1.07ã-2.94%äžåããçŽè¿å®å€-268.13ã-24213.66%äžåã£ãŠããŸãã
ããªã¥ãšãŒã·ã§ã³
PER
PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
PSR
PCFR
æ¥çå
é äœ 43/206

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæž¬å€
é貚: USD æŽæ°æå»: 2025-12-24Enovis Corpã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.40ã§ãå»çæ©åš & å忥çã§ã¯38/206äœã§ãã Enovis Corpã®å¹³åç®æšæ ªäŸ¡ã¯49.00ã§ãæé«ç®æšæ ªäŸ¡ã¯58.00ãæäœç®æšæ ªäŸ¡ã¯33.00ã§ãã
ç®æšæ ªäŸ¡

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Zimmer Biomet Holdings Inc
ZBH
30
財åäºæž¬

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
ã¢ã¡ã³ã¿ã
é貚: USD æŽæ°æå»: 2025-12-24Enovis Corpã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯6.72ã§ãå»çæ©åš & å忥çã§ã¯116/206äœã§ãã çŸåšãæ ªäŸ¡ã¯æµæç·30.02ãšæ¯æç·24.61ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
æ¯æç·ã𿵿ç·

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ææš
î°
î°
æ¬ææšæ©èœã¯ãåçš®ãã¯ãã«ã«ææšãçšããŠéèååã®æ°å€åæãšæ¹åæ§è©äŸ¡ãæäŸããæè¡çãªèŠçŽã衚瀺ããŸãã
æ¬æ©èœã§ã¯MACDã»RSIã»KDJã»StochRSIã»ATRã»CCIã»WRã»TRIXã»MAã®9çš®é¡ã®äž»èŠãã¯ãã«ã«ææšãç¶²çŸ
ããŠããŸããæé軞ã¯ãèªèº«ã®ããŒãºã«åãããŠèª¿æŽå¯èœã§ãã
ãã¯ãã«ã«åæã¯æè³å€æã®äžèŠçŽ ã«éãããæ°å€ã«ããæ¹åæ§è©äŸ¡ã«çµ¶å¯Ÿçãªåºæºã¯ãããŸãããè¡šç€ºçµæã¯ãããŸã§åèæ
å ±ã§ãããææšèšç®ã»èŠçŽã®æ£ç¢ºæ§ã«ã€ããŠåœæ¹ã¯è²¬ä»»ãè² ããããŸãã
ææš
売ã(2)
äžç«(4)
è²·ã(1)
ç§»åå¹³å
売ã(6)
äžç«(0)
è²·ã(0)
æ©é¢æè³å®¶ããã®è©äŸ¡
é貚: USD æŽæ°æå»: 2025-12-24Enovis Corpã®çŸåšã®æ©é¢æè³å®¶ææ ªã¹ã³ã¢ã¯10.00ã§ãå»çæ©åš & å忥çå
ã§1/206äœã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯125.63%ã§ãåååææ¯æžå°2.05%ã§ãã æå€§ã®æ©é¢æè³å®¶ã¯ãã³ã¬ãŒãã§ãåèš6.49Mæ ªïŒçºè¡æžæ ªåŒã®11.35%ïŒãä¿æããŠãããä¿ææ¯çã¯å¢å 6.60%ã§ãã
æ©é¢æè³å®¶ä¿ææ ª

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»åå
BlackRock Institutional Trust Company, N.A.
American Century Investment Management, Inc.
Dimensional Fund Advisors, L.P.
Davenport Asset Management
Dorsey Asset Management LLC
State Street Investment Management (US)
Hood River Capital Management LLC
River Road Asset Management, LLC
ãªã¹ã¯î°î°
é貚: USD æŽæ°æå»: 2025-12-24Enovis Corpã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯6.25ã§ãå»çæ©åš & å忥çå
ã§62/206äœã§ãã å瀟ã®ããŒã¿å€ã¯1.29ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯ãã倧ããªäžèœãçµéšããããšã瀺ããŠããŸãã
S&P 500ææ°ãšã®ããŒã¿å€
1.29
éå»240æ¥éã®æå€§ãããŒããŠã³
+46.36%
éå»240æ¥ã®ãã©ãã£ãªãã£
+48.61%
æ»ã
æ¥æ¬¡ãªã¿ãŒã³ïŒæå€§ïŒ
æ¥æ¬¡ãªã¿ãŒã³ïŒæå°ïŒ
ãªã¹ã¯
ãªã¿ãŒã³/ãããŒããŠã³æ¯ç
ãã©ãã£ãªãã£
å®çŸãã©ãã£ãªãã£
æšæºåãã¥ã«ãŒã¬ã³ãž
ããŠã³ãµã€ããªã¹ã¯èª¿æŽåŸãªã¿ãŒã³
æå€§æ¥æ¬¡äžæãã©ãã£ãªãã£
æå€§æ¥æ¬¡äžèœãã©ãã£ãªãã£
æµåæ§
売買å転çã®å€åå¹
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯

Edwards Lifesciences Corp
EW
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯

Lantheus Holdings Inc
LNTH
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯

Tactile Systems Technology Inc
TCMD
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
äºæž¬å€
ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ããã®è©äŸ¡
ãªã¹ã¯
詳现ãèŠã
ãããã質å
TradingKeyã¯ã©ã®ããã«ããŠEnovis Corpã®æ ªåŒã¹ã³ã¢ãç®åºãããŸããïŒ
îTradingKeyæ ªåŒã¹ã³ã¢ã¯ã100以äžã®åºç€ããŒã¿ããå°ããã34ã®ææšã«åºã¥ããEnovis Corpãå
æ¬çã«è©äŸ¡ããŸãããããã®ææšã¯ã財åå¥å
šæ§ãäŒæ¥ãããã£ãŒã«ãåçäºæž¬ãæ ªäŸ¡ã¢ã¡ã³ã¿ã ãæ©é¢æè³å®¶ã®ä¿¡é ŒåºŠããªã¹ã¯è©äŸ¡ã®6ã€ã®äž»èŠãªãã£ã¡ã³ã·ã§ã³ã«åé¡ãããæè³å®¶ã«Enovis Corpã®ããã©ãŒãã³ã¹ãšèŠéããå€è§çã«æç€ºããŸãã
Enovis Corpã®è²¡åå¥å
šæ§ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îEnovis Corpã®è²¡åå¥å
šæ§ã¹ã³ã¢ãçæããã«ãããã財ååºç€ãåçã®è³ªãéå¶å¹çãæé·å¯èœæ§ãæ ªäž»ãžã®ãªã¿ãŒã³ãªã©ãè€æ°ã®äž»èŠãªèгç¹ããåçš®è²¡åææšãåæããŠããŸãããããã®å
æ¬çãªããŒã¿ãçµ±åããããšã§ã財åå¥å
šæ§ã¹ã³ã¢ã¯Enovis Corpã®å®å®æ§ãéå¶å¹çãæé·æ§ããã³æ ªäž»ãžã®ãªã¿ãŒã³ãåæ ããæè³å®¶ãå©å®³é¢ä¿è
ã®åççãªæææ±ºå®ããµããŒãããŸããã¹ã³ã¢ãé«ãã»ã©ãEnovis Corpã®è²¡åå¥å
šæ§ãè¯å¥œã§ããããšã瀺ããŸãã
Enovis Corpã®äŒæ¥äŸ¡å€è©äŸ¡ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îEnovis Corp ã®äŒæ¥äŸ¡å€è©äŸ¡ã¹ã³ã¢ãç®åºããããã«ãP/EãP/BãP/Sãããã³ P/CF ãå«ãè€æ°ã®äž»èŠãªè²¡åææšã䜿çšããŸãããããã®ææšã¯ãEnovis Corp ã®åžå ŽäŸ¡å€ãå©çãè³ç£ã売äžããã£ãã·ã¥ãããŒãšæ¯èŒããããšã§ãäŒæ¥äŸ¡å€ãè©äŸ¡ããããã®äž»èŠãªææšãšãªããŸãããããã®ææšãç·åçã«åæããããšã§ãè©äŸ¡ã¹ã³ã¢ã¯åžå ŽãçŸåšã©ã®ããã« Enovis Corp ã®äŸ¡å€ãæããŠãããã ãã§ãªããå°æ¥ã®åçåãæé·å¯èœæ§ãåæ ããããæ
å ±ã«åºã¥ããæè³å€æãæ¯æŽããŸããã¹ã³ã¢ãé«ãã»ã©ãEnovis Corp ã®è©äŸ¡ããã劥åœã§ããããšã瀺ããŸãã
Enovis Corpã®åçäºæž¬ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îEnovis Corpã®åçäºæž¬ã¹ã³ã¢ãç®åºããéã«ã¯ãã¢ããªã¹ãè©äŸ¡ã財åäºæž¬ããµããŒãããã³ã¬ãžã¹ã¿ã³ã¹æ°Žæºã忥ä»ç€Ÿãšã®æ¯èŒãšãã£ãããŸããŸãªäž»èŠææšãèæ
®ããŸããçŸåšã®è©äŸ¡ããã³ç®æšæ ªäŸ¡ã¯ã¢ããªã¹ãã®æåŸ
ãçŽæ¥åæ ããŠãããäžæäœå°ã¯éæã®æé·å¯èœæ§ã«å¯ŸããèŠè§£ã瀺ããŸãã1æ ªåœããå©çïŒEPSïŒã売äžé«ãçŽå©çã婿ãã»çšåŒãåå©çïŒEBITïŒãªã©ã®è²¡åææšã¯ãåçæ§ãè©äŸ¡ããããã®äžå¿çãªåºæºãšãªããŸããç®æšæ ªäŸ¡ã®é«å€ã»äžå€®å€ã»å®å€ã®ã¬ã³ãžãåæããããšã«ãããäŸ¡æ Œãã¬ã³ããææ¡ããäž»èŠãªãµããŒãããã³ã¬ãžã¹ã¿ã³ã¹æ°Žæºãç¹å®ã§ããŸãããããã®ææšã忥ä»ç€Ÿãšæ¯èŒããããšã§ãéæã®ããã©ãŒãã³ã¹ã«æèãäžããããããçŸå®çãªæåŸ
å€ãèšå®ããã®ã«åœ¹ç«ã¡ãŸãããããã®èŠçŽ ãç·åããŠåœ¢æãããåçäºæž¬ã¹ã³ã¢ã¯ãéæã®æåŸ
ããã財åããã©ãŒãã³ã¹ãšæé·å¯èœæ§ãæ£ç¢ºã«åæ ããŸããã¹ã³ã¢ãé«ãã»ã©ãã¢ããªã¹ããEnovis Corpã®å°æ¥ã«å¯ŸããŠããæ¥œèгçã§ããããšã瀺ããŸãã
Enovis Corpã®æ ªäŸ¡ã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îEnovis Corpã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ãç®åºããéããµããŒãã¬ãã«ãã¬ãžã¹ã¿ã³ã¹ã¬ãã«ãåºæ¥é«ææšãªã©ã®ã¢ã¡ã³ã¿ã ææšãåæããŸãããµããŒãã¬ãã«ã¯ãè²·ãã®é¢å¿ã匷ããããã«äžèœããªãããäŸ¡æ Œãæ¯ããæ°Žæºãæå³ããŸããäžæ¹ãã¬ãžã¹ã¿ã³ã¹ã¬ãã«ã¯ã売ãå§åã«ãã£ãŠäŸ¡æ Œã®äžæãæããããæ°Žæºã瀺ããŸããå
žåçãªäŸ¡æ Œåž¯ã«ãããåºæ¥é«ãšç·åºæ¥é«ã®äž¡æ¹ãåæããããšã§ãåžå Žå
šäœã®æŽ»åç¶æ³ããã³æµåæ§ãè©äŸ¡ããŸãããããã®ææšã掻çšããããšã§ãäŸ¡æ Œãã¬ã³ãããã®å€åã®å¯èœæ§ãææ¡ããå°æ¥ã®åçãããæ£ç¢ºã«äºæž¬ããããšãã§ããŸãããã®å
æ¬çãªææ³ã¯åžå Žã»ã³ãã¡ã³ããåæ ããEnovis Corpã®äŸ¡æ Œã«é¢ããåççãªäºæž¬ãå¯èœã«ããŸããã¹ã³ã¢ãé«ãã»ã©ãEnovis Corpã®çæçãªäŸ¡æ Œãã¬ã³ããããå®å®ããŠããããšã瀺ããŸãã
Enovis Corpã®æ©é¢æè³å®¶ä¿¡é ŒåºŠã¹ã³ã¢ã¯ã©ã®ããã«ç®åºãããŸããïŒ
îEnovis Corpã®æ©é¢ä¿¡é ŒåºŠã¹ã³ã¢ãç®åºããããã«ãæ©é¢ã«ããæ ªåŒã®ä¿ææ¯çãšä¿ææ ªæ°ã®äž¡æ¹ãåæããŸããæ©é¢ã®ä¿ææ¯çãé«ãããšã¯ãããæè³å®¶ãEnovis Corpã«å¯ŸããŠåŒ·ãä¿¡é Œãæã£ãŠããããšã瀺ããäžè¬çã«ããžãã£ããªã·ã°ãã«ãšãããŠããŸããä¿ææ ªæ°ã確èªããããšã§ãæ©é¢ããã®æ ªåŒãžã©ãã»ã©ã³ãããããŠããããã©ã®ãããªå§¿å¢ããšã£ãŠãããã«ã€ããŠããæ·±ãæŽå¯ãåŸãããŸããæ©é¢æè³å®¶ã¯ãæè³å€æã«å
ç«ã£ãŠç¶¿å¯ãªåæãè¡ãã®ãäžè¬çã§ããããããæ©é¢ä¿¡é ŒåºŠãææ¡ããããšã§ãå©çäºæž¬ãæé©åã§ããäŒæ¥ã®å°æ¥çãªæ¥çžŸãåžå Žã®å®å®æ§ã«é¢ããããä¿¡é Œæ§ã®é«ãèŠç¹ãåŸãããŸããã¹ã³ã¢ãé«ãã»ã©ãEnovis Corpã«å¯Ÿããæ©é¢ã®æ¯æã匷ãããšã瀺ããŸãã
ç§ãã¡ã¯ã©ã®ããã«ããŠEnovis Corpã®ãªã¹ã¯ç®¡çã¹ã³ã¢ãç®åºããŠããŸããïŒ
îEnovis Corpã®ãªã¹ã¯ç®¡çã¹ã³ã¢ãè©äŸ¡ããã«ããããåçããªã¹ã¯ããã©ãã£ãªãã£ãæµåæ§ã«é¢é£ããè€æ°ã®äž»èŠææšãåæããŸãã1æ¥ã®æé«ããã³æäœãªã¿ãŒã³ã¯å©çããã³æå€±ã®æœåšçãªèŠæš¡ã瀺ããã·ã£ãŒãã¬ã·ãªã¯ãªã¹ã¯èª¿æŽåŸã®ãªã¿ãŒã³ããã©ãŒãã³ã¹ã枬å®ããŸãããªã¹ã¯é¢ã§ã¯ãæå€§ãããŒããŠã³ããã³ãªã¿ãŒã³ãšãããŒããŠã³ã®æ¯çãåæããæ¥µç«¯ãªæå€±ã®ã·ããªãªãç¹å®ããŸããæªåºŠã«ãã£ãŠãªã¿ãŒã³ã®ååžãããã©ãŒãã³ã¹ã«åããããããè©äŸ¡ããŸããå®çŸãã©ãã£ãªãã£ãæšæºåãã¥ã«ãŒã¬ã³ãžãšãã£ããã©ãã£ãªãã£ææšã¯äŸ¡æ Œå€åã瀺ããäžæ¹ãªã¹ã¯èª¿æŽåŸãªã¿ãŒã³ã¯æœåšçãªæå€±ããã³å©çã«é¢ããã€ã³ãµã€ããæäŸããŸããæåŸã«ãå¹³å売買å転çãå転çä¹é¢ãšãã£ãæµåæ§ææšãããã®æ ªåŒã®ååŒãã©ãã ãæŽ»çºãã瀺ããŸãããããã®ææšãçµã¿åãããããšã§ãEnovis Corpã®ãªã¹ã¯ããã³ãªã¿ãŒã³ã®ãããã¡ã€ã«ãå€é¢çã«çè§£ã§ãããªã¹ã¯ç®¡çã¹ã³ã¢ã®äžæ žçèŠçŽ ãšãªããŸããã¹ã³ã¢ãé«ãã»ã©ãEnovis Corpã®ãªã¹ã¯ã¯äœãããšã瀺ããŸãã